17. Believes that ERDF funding alone will not be enough to allow the ORs to meet the Europe 2020 and Horizon 2020 targets; considers, in this connection, that the Commission should make the necessary adjustments and guarantee OR access to the Horizon 2020 programme by setting up dedicated programmes that can help to foster greater OR inclusion in European and international research and innovation networks; points out in this connection that the Horizon 2020 strategy itself, in its 'Spreading Excellence and Widening Participation' section, draws attention to significant disparities, as identified in the Innovation Union Scoreboard, betw ...[+++]een research and innovation performance and the specific measures for spreading excellence and widening participation in Member States and regions that are low-performing in terms of research and innovation;

Maintain the EU’s coordinative role in the development of the EU policy on rare diseases and to support Member States in their activities on the national level. Continue to support the development of high quality National Rare Diseases Plans/Strategies in the European Union. Provide continued support for the International Rare Disease Research Consortium and initiatives developed under its umbrella. Continue to ensure proper codification of rare diseases. Work further to decrease inequalities between patients with rare diseases and patients suffering from more common disorders and to support initiatives promoting equal access to diagnosis and treatment. Continue to promote patients empowerment in all aspects of rare diseases policy developm ...[+++]ent Continue activities increasing public awareness about rare diseases and EU activity in this field Make use of the Directive 2011/24/EU on the application of patients’ rights in cross-border healthcare to bring together European Reference Networks on rare diseases. Support the development of the tools facilitating cooperation and interoperability of the European Reference Networks for rare diseases. Stimulate development and use of eHealth solutions in the area of rare diseases. Implement and continue support for the European Platform on rare diseases registration. Continue playing a global role in the rare diseases initiative and collaborating with important international stakeholders.

Maintain the EU’s coordinative role in the development of the EU policy on rare diseases and to support Member States in their activities on the national level. Continue to support the development of high quality National Rare Diseases Plans/Strategies in the European Union. Provide continued support for the International Rare Disease Research Consortium and initiatives developed under its umbrella. Continue to ensure proper codification of rare diseases. Work further to decrease inequalities between patients with rare diseases and patients suffering from more common disorders and to support initiatives promoting equal access to diagnosis and treatment. Continue to promote patients empowerment in all aspects of rare diseases policy developm ...[+++]ent Continue activities increasing public awareness about rare diseases and EU activity in this field Make use of the Directive 2011/24/EU on the application of patients’ rights in cross-border healthcare to bring together European Reference Networks on rare diseases. Support the development of the tools facilitating cooperation and interoperability of the European Reference Networks for rare diseases. Stimulate development and use of eHealth solutions in the area of rare diseases. Implement and continue support for the European Platform on rare diseases registration. Continue playing a global role in the rare diseases initiative and collaborating with important international stakeholders.

A dedicated block of C class subnet has currently been allocated by the European IP registration authority (RIPE) to TESTA. Further address blocks may be allocated to TESTA in the future if required.

A dedicated block of C class subnet has currently been allocated by the European IP registration authority (RIPE) to TESTA. Further address blocks may be allocated to TESTA in the future if required.

It also encourages the promotion of women in the business world by creating networks for women active in the liberal professions and in business, and by facilitating access for women to financial instruments.